Halozyme Therapeutics

ISIN US40637H1095

 | 

WKN A0DLHS

Market cap (in EUR)
6,950 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.
Show more Show less
Healthcare Biopharmaceuticals Non-System-Specific Biopharmaceuticals United States

Financials

Key metrics

Market capitalisation, EUR 6,950 m
EPS, EUR 2.21
P/B ratio 167.8
P/E ratio 27.2
Dividend yield 0.00%

Income statement (2025)

Revenue, EUR 1,238 m
Net income, EUR 281 m
Profit margin 22.69%

What ETF is Halozyme Therapeutics in?

There are 4 ETFs which contain Halozyme Therapeutics. All of these ETFs are listed in the table below. The ETF with the largest weighting of Halozyme Therapeutics is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
ETF Weight Investment focus Fund size (in m EUR)
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 0.65%
Equity
United States
Health Care
Biotech
49
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.01%
Equity
World
Social/Environmental
494
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing 0.01%
Equity
North America
Social/Environmental
24
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0.15%
Equity
United States
Small Cap
191
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.